Biological
H56 clinical trials
Also written AERAS-456.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Aeras (4) · International AIDS Vaccine Initiative (1) · Anne Margarita Dyrhol Riise (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses H56 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study to Evaluate H56:IC31 in Preventing Rate of TB RecurrenceCompletedPhase 2International AIDS Vaccine InitiativeNCT03512249Written as H56:IC31
- A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TBCompletedPhase 1AerasNCT02375698Written as H56:IC31
- Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis PandemicCompletedPhase 1Anne Margarita Dyrhol RiiseNCT02503839Written as H56:IC31
- Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy AdolescentsCompletedPhase 1AerasNCT02378207Written as H56:IC31
- Safety and Immunogenicity Study of AERAS-456 Vaccine for TuberculosisCompletedPhase 1AerasNCT01967134Written as H56:IC31
- A Phase II Study of H56:IC31 in Healthy AdolescentsWithdrawnPhase 2AerasNCT03265977Written as H56:IC31